Brief: PledPharma Q4 Net Loss Widens To SEK 32.1 Million
Feb 22 (Reuters) - PLEDPHARMA AB (PUBL) PLED.ST :
* Q4 NET LOSS SEK 32.1 MILLION VERSUS LOSS SEK 11.5
MILLION YEAR
AGO
Source text for Eikon: ID:nSSN7mq2
Further company coverage: PLED.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1